Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.50 |
| ▸ | PRKCA | P17252 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.36 |
| ▸ | TP53 | P04637 | 1/20 | 0.36 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 2/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.34 |
| ▸ | LMNA | P02545 | 2/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1322672 | 0.92 | PRKCA (0.44) | NPSR1PRKCAALDH1A1MEN1KMT2A | |
| SCHEMBL6559851 | 0.85 | NPSR1 (0.58) | NPSR1L3MBTL1ALDH1A1RXFP1MEN1 | |
| SCHEMBL7800500 | 0.83 | NPSR1 (0.47) | NPSR1PRKCAL3MBTL1ALDH1A1TP53 | |
| SCHEMBL7791073 | 0.80 | NPSR1 (0.56) | NPSR1L3MBTL1ALDH1A1RXFP1MEN1 | |
| SCHEMBL7799311 | 0.80 | NPSR1 (0.56) | NPSR1L3MBTL1ALDH1A1RXFP1MEN1 | |
| SCHEMBL7797293 | 0.79 | NPSR1 (0.55) | NPSR1L3MBTL1ALDH1A1RXFP1MEN1 | |
| SCHEMBL7797332 | 0.79 | NPSR1 (0.55) | NPSR1L3MBTL1ALDH1A1RXFP1MEN1 | |
| SCHEMBL18315201 | 0.78 | NPSR1 (0.53) | NPSR1L3MBTL1ALDH1A1LMNA | |
| SCHEMBL7797407 | 0.78 | NPSR1 (0.47) | NPSR1PRKCAL3MBTL1ALDH1A1TP53 | |
| SCHEMBL10150638 | 0.78 | NPSR1 (0.50) | NPSR1L3MBTL1ALDH1A1RXFP1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170306062-A1 | CURABLE COMPOSITION, RESIST MATERIAL AND RESIST FILM | DIC CORPORATION (JP) | 2017-10-26 | — | — | US | disclosed |
| US-20170306062-A1 | CURABLE COMPOSITION, RESIST MATERIAL AND RESIST FILM | DIC CORPORATION (JP) | 2017-10-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170306062-A1 | CURABLE COMPOSITION, RESIST MATERIAL AND RESIST FILM | FEM1B, WDR1, SMARCA1 | NPSR1 3240/4885PRKCA 1508/4885L3MBTL1 1582/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.